Canonical and noncanonical hedgehog pathway in the pathogenesis of multiple myeloma

Blood

Volumn 120, Issue 25, 2012, Pages 5002-5013

  Blotta, Simona ^a,b,c   Jakubikova, Jana ^a,d   Calimeri, Teresa ^a,b   Roccaro, Aldo M ^a   Amodio, Nicola ^b   Azab, Abdel Kareem ^a   Foresta, Umberto ^b   Mitsiades, Constantine S ^a   Rossi, Marco ^b   Todoerti, Katia ^e   Molica, Stefano ^c   Morabito, Fortunato ^f   Neri, Antonino ^e   Tagliaferri, Piersandro ^b   Tassone, Pierfrancesco ^b   Anderson, Kenneth C ^a   Munshi, Nikhil C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c PUGLIESE CIACCIO HOSPITAL   (Italy)

^d Department of Tumor Immunology and VVCE CeXignal ^*  (Slovakia)

^e UNIVERSITY OF MILAN   (Italy)

^f Unit of Geriatrics   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; FORSKOLIN; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; SONIDEGIB; SYNDECAN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; MOUSE; MULTIPLE MYELOMA; MYELOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

EID: 84879165722     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-07-368142     Document Type: Article

References (49)

1. Ingham PW, McMahon A. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001;15(23):3059-3087. (Pubitemid 33115673)
2. Taipale J, Beachy PA. The Hedgehog and Wnt signaling pathways in cancer. Nature. 2001; 411(6835):349-354. (Pubitemid 32467044)
3. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432(7015):324-331. (Pubitemid 39551660)
4. Mullor JL, Sanchez P, Ruiz i Altaba A. Pathway and consequences: Hedgehog signaling in human disease. Trends Cell Biol. 2002;12(12):562-569.
5. Kinzler KW, Bigner SH, Bigner DD, et al. Identification of an amplified highly expressed gene in human glioma. Science. 1987;236(4797):70-73. (Pubitemid 17056814)
6. Johnson RL, Rothman AL, Xie J, et al. Human homolog of Patched, a candidate gene for basal cell nevus syndrome. Science. 1996;272(5268):1668-1671. (Pubitemid 26200029)
7. Lee Y, Miller HL, Jensen P, et al. A molecular fingerprint for medulloblastoma. Cancer Res. 2003; 63(17):5428-5437. (Pubitemid 37139861)
8. Davies FE, Dring AM, Li C, et al. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood. 2003;102(13):4504-4511. (Pubitemid 37494117)
9. Peacock CD, Wang Q, Gesell GS, et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A. 2007;104(10):4048-4053. (Pubitemid 47181576)
10. Matsui W, Wang Q, Barber JP, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 2008; 68(1):190-197. (Pubitemid 351380120)
11. Dierks C, Grbic J, Zirlik K, et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med. 2007;13(8):944-951. (Pubitemid 47222041)
12. Blotta S, Tassone P, Prabhala RH, et al. Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance. Blood. 2009;114(15):3276-3284.
13. Rubin LL, De Sauvage FJ. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov. 2006;5(12):1026-1033. (Pubitemid 44835129)
14. Lauth M, Toftgard R. Non-canonical activation of Gli transcription factors. Cell Cycle. 2007;6(20):2458-2463.
15. Christensen ST, Ott CM. Cell signaling: a ciliary signaling switch. Science. 2007;317(5836):330-331.
16. Pan S, Wu X, Jiang J, et al. Discovery of NVPLDE225, a potent and selective smoothened antagonist [letter]. ACS Med Chem Lett. 2010;1:130-134.
17. Buonamici S, Williams J, Morrissey M, et al. Interfering with resistance to Smoothened antagonist by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med. 2010;2(51):51ra70.
18. Agnelli L, Forcato M, Ferrari F, et al. The reconstruction of transcriptional networks reveals critical genes with implications for clinical outcome of multiple myeloma. Clin Cancer Res. 2011;17(23):7402-7412.
19. Irizzarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249-264.
20. Jakubikova J, Cervi D, Ooi M, et al. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforafane and phenethyl isothiocyanate, in multiple myeloma. Haematologica. 2011;96(8):1170-1179.
21. Regl G, Kasper M, Schnidar H, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 2004;64(21):7724-7731. (Pubitemid 39446903)
22. Taniguchi E, Cho MJ, Arenkiel BR, et al. Bortezomib reverses a post-translational mechanism of tumorigenesis for Patched1 haploinsufficiency in medulloblastoma. Pediatr Blood Cancer. 2009; 53(2):136-144.
23. Peukert S, Miller-Moslin K. Small-molecule inhibitors of the Hedgehog signaling pathway as cancer therapeutics. Chem Med Chem. 2010;5(4):500-512.
24. LoRusso PM, Rudin CM, Reddy JC, et al. Phase I trial of Hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res. 2011;17(8):2502-2511.
25. Bhardwaj G, Murdoch B, Wu D, et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol. 2001;2(2):172-180. (Pubitemid 33707938)
26. Merchant A, Joseph G, Wang Q, Brennan S, Matsui W. Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood. 2010;115(12):2391-2396.
27. Trowbridge JJ, Scott MP, Bhatia M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc Natl Acad Sci U S A. 2006;103(38):14134-14139. (Pubitemid 44452992)
28. Hofmann I, Stover EH, Culler DE, et al. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell. 2009;4(6):559-567.
29. Gao J, Graves S, Koch U, et al. Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell. 2009;4(6):548-558.
30. Gutierrez-Frìas C, Sacedòn R, Hernàndez-Lòpez C, et al. Sonic Hedgehog regulates early human thymocyte differentiation by counteracting the IL-7-induced development of CD34+ precursor cells. J Immunol. 2004;173(8):5046-5053. (Pubitemid 39387787)
31. Crompton T, Outram SV, Hager-Theodorides AL. Sonic hedgehog signaling in T-cell development and activation. Nat Rev Immunol. 2007;7(9):726-735. (Pubitemid 47327392)
32. Uhmann A, Dittmann K, Nitzki F, et al. The Hedgehog receptor Patched controls lymphoid lineage commitment. Blood. 2007;110(6):1814-1823. (Pubitemid 47443892)
33. Varas A, Hernàndez-Lòpez C, Valencia J, et al. Survival and function of human thymic dendritic cells are dependent on autocrine Hedgehog signaling. J Leukoc Biol. 2008;83(6):1476-1483. (Pubitemid 351960329)
34. Sacedòn R, Dìez B, Nunez V, et al. Sonic hedgehog is produced by follicular dendritic cells and protects germinal center B cells from apoptosis. J Immunol. 2005;174(3):1456-1461.
35. Okamoto OK, Carvalho AC, Marti LC, Vencio RZ, Moreira-Filho CA. Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer. Cancer Cell Int. 2007;7:11.
36. Kobune M, Takimoto R, Murase K, et al. Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells. Cancer Sci. 2009;100(5):948-955.
37. Ji Z, Mei FC, Johnson BH, Thompson EB, Cheng X. Protein kinase A, not Epac, suppresses Hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells. J Biol Chem. 2007;282(52):37370-37377.
38. Dierks C, Beigi R, Guo GR, et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on hedgehog pathway activation. Cancer Cell. 2008;14(3):238-249.
39. Zhao C, Chen A, Jamieson CH, et al. Hedgehog signaling is essential for maintenance of cancer stem cells in myeloid leukemia. Nature. 2009; 458(7239):776-790.
40. Sengupta A, Banerjee D, Chandra S, et al. Deregulation and cross talk among Sonic Hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia. 2007; 21(5):949-955. (Pubitemid 46672071)
41. Singh RR, Cho-Vega JH, Davuluri Y, et al. Sonic Hedgehog signaling pathway is activated in ALKpositive anaplastic large cell lymphoma. Cancer Res. 2009;69(6):2550-2558.
42. Hedge GV, Munger CM, Emanuel K, et al. Targeting the sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma. Mol Cancer Ther. 2008;7(6):1450-1460.
43. Singh RR, Kim JE, Davuluri Y, et al. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia. 2010;24(5):1025-1036.
44. Hedge GV, Peterson KJ, Emanuel K, et al. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Mol Cancer Res. 2008;6(12):1928-1936.
45. Desch P, Asslaber D, Kern D, et al. Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells. Oncogene. 2010;29(35):4885-4895.
46. Jakubikova J, Adamia S, Kost-Alimova M, et al. Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood. 2011;117(17):4409-4419.
47. Huff CA, Matsui W. Multiple myeloma cancer stem cells. J Clin Oncol. 2008;26(17):2895-2900.
48. Brennan SK, Matsui W. Cancer stem cells: controversies in multiple myeloma. J Mol Med. 2009; 87(11):1079-1085.
49. Jenkins D. Hedgehog signaling: emerging evidence for non-canonical pathways. Cell Signal. 2009;21(7):1023-1034.